SMT201500175B - Derivati di azaindoli come inibitori delle proteine chinasi abl e src - Google Patents
Derivati di azaindoli come inibitori delle proteine chinasi abl e srcInfo
- Publication number
- SMT201500175B SMT201500175B SM201500175T SM201500175T SMT201500175B SM T201500175 B SMT201500175 B SM T201500175B SM 201500175 T SM201500175 T SM 201500175T SM 201500175 T SM201500175 T SM 201500175T SM T201500175 B SMT201500175 B SM T201500175B
- Authority
- SM
- San Marino
- Prior art keywords
- inhibitors
- azaindole derivatives
- src proteins
- kinase abl
- abl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20227909P | 2009-02-12 | 2009-02-12 | |
FR0900631A FR2941948B1 (fr) | 2009-02-12 | 2009-02-12 | Derives d'azaindoles en tant qu'inhibiteur des proteines kinases abl et src |
PCT/IB2010/000593 WO2010092489A1 (en) | 2009-02-12 | 2010-02-12 | Derivatives of azaindoles as inhibitors of protein kinases abl and src |
Publications (1)
Publication Number | Publication Date |
---|---|
SMT201500175B true SMT201500175B (it) | 2015-09-07 |
Family
ID=40886859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SM201500175T SMT201500175B (it) | 2009-02-12 | 2015-07-22 | Derivati di azaindoli come inibitori delle proteine chinasi abl e src |
Country Status (15)
Country | Link |
---|---|
US (1) | US8580815B2 (xx) |
EP (1) | EP2396325B1 (xx) |
JP (1) | JP5583698B2 (xx) |
AU (1) | AU2010212560B2 (xx) |
CA (1) | CA2751478A1 (xx) |
DK (1) | DK2396325T3 (xx) |
ES (1) | ES2540962T3 (xx) |
FR (1) | FR2941948B1 (xx) |
HR (1) | HRP20150697T8 (xx) |
HU (1) | HUE024989T2 (xx) |
PL (1) | PL2396325T3 (xx) |
PT (1) | PT2396325E (xx) |
SI (1) | SI2396325T1 (xx) |
SM (1) | SMT201500175B (xx) |
WO (1) | WO2010092489A1 (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015014752B1 (pt) | 2012-12-21 | 2022-07-05 | Plexxikon, Inc | Compostos e seus uso para modulação de cinase |
FR3000492B1 (fr) * | 2012-12-28 | 2015-09-11 | Oribase Pharma | Nouveaux derives azaindole en tant qu'inhibiteurs multikinases |
FR3000494B1 (fr) * | 2012-12-28 | 2015-08-21 | Oribase Pharma | Nouveaux derives d'azaindoles en tant qu'inhibiteurs de proteines kinases |
FR3000493A1 (fr) * | 2012-12-28 | 2014-07-04 | Oribase Pharma | Nouveaux inhibiteurs de proteines kinases |
WO2017156350A1 (en) | 2016-03-09 | 2017-09-14 | K-Gen, Inc. | Methods of cancer treatment |
SG11201908569QA (en) | 2017-03-21 | 2019-10-30 | Arbutus Biopharma Corp | Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same |
CN111943947B (zh) * | 2020-07-24 | 2021-04-30 | 重庆文理学院 | 1H-吡咯[2,3-b]吡啶衍生物及其合成方法与应用 |
MX2023003995A (es) | 2020-10-05 | 2023-06-12 | Enliven Inc | Compuestos de 5-y 6-azaindol para la inhibicion de tirosina cinasas bcr-abl. |
CN116438182A (zh) * | 2020-10-05 | 2023-07-14 | 活力疗法公司 | 用于抑制bcr-abl酪氨酸激酶的7-氮杂吲哚化合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0330043D0 (en) * | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them |
GB0330042D0 (en) | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them |
CA2570817A1 (en) * | 2004-06-17 | 2006-01-26 | Plexxikon, Inc. | Azaindoles modulating c-kit activity and uses therefor |
US7361764B2 (en) | 2004-07-27 | 2008-04-22 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
CA2573362A1 (en) | 2004-07-27 | 2006-02-09 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
US7709645B2 (en) * | 2004-07-27 | 2010-05-04 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
EP1863792B1 (en) * | 2005-03-28 | 2009-01-21 | Brystol-Myers Squibb Company | Atp competitive kinase inhibitors |
CA2662031A1 (en) * | 2006-09-06 | 2008-03-13 | F. Hoffmann-La Roche Ag | Heteroaryl derivatives as protein kinase inhibitors |
US8148361B2 (en) * | 2006-11-10 | 2012-04-03 | Bristol-Myers Squibb Company | Kinase inhibitors |
WO2008144253A1 (en) * | 2007-05-14 | 2008-11-27 | Irm Llc | Protein kinase inhibitors and methods for using thereof |
KR20100122505A (ko) * | 2008-02-29 | 2010-11-22 | 어레이 바이오파마 인크. | Raf 저해물질 화합물 및 이들의 이용 방법 |
HUE035798T2 (en) * | 2008-11-03 | 2018-05-28 | Syntarga Bv | CC-1065 analogues and conjugates |
-
2009
- 2009-02-12 FR FR0900631A patent/FR2941948B1/fr not_active Expired - Fee Related
-
2010
- 2010-02-12 JP JP2011549698A patent/JP5583698B2/ja not_active Expired - Fee Related
- 2010-02-12 SI SI201030964T patent/SI2396325T1/sl unknown
- 2010-02-12 DK DK10710439.0T patent/DK2396325T3/en active
- 2010-02-12 PT PT107104390T patent/PT2396325E/pt unknown
- 2010-02-12 HU HUE10710439A patent/HUE024989T2/en unknown
- 2010-02-12 PL PL10710439T patent/PL2396325T3/pl unknown
- 2010-02-12 WO PCT/IB2010/000593 patent/WO2010092489A1/en active Application Filing
- 2010-02-12 EP EP10710439.0A patent/EP2396325B1/en not_active Not-in-force
- 2010-02-12 US US13/148,988 patent/US8580815B2/en not_active Expired - Fee Related
- 2010-02-12 CA CA2751478A patent/CA2751478A1/en not_active Abandoned
- 2010-02-12 ES ES10710439.0T patent/ES2540962T3/es active Active
- 2010-02-12 AU AU2010212560A patent/AU2010212560B2/en not_active Ceased
-
2015
- 2015-06-30 HR HRP20150697TT patent/HRP20150697T8/hr unknown
- 2015-07-22 SM SM201500175T patent/SMT201500175B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2941948A1 (fr) | 2010-08-13 |
PL2396325T3 (pl) | 2015-10-30 |
SI2396325T1 (sl) | 2015-08-31 |
HRP20150697T1 (hr) | 2015-08-14 |
DK2396325T3 (en) | 2015-06-29 |
WO2010092489A1 (en) | 2010-08-19 |
JP5583698B2 (ja) | 2014-09-03 |
US20110312959A1 (en) | 2011-12-22 |
AU2010212560A1 (en) | 2011-08-11 |
JP2012517465A (ja) | 2012-08-02 |
FR2941948B1 (fr) | 2013-04-05 |
HUE024989T2 (en) | 2016-01-28 |
EP2396325A1 (en) | 2011-12-21 |
US8580815B2 (en) | 2013-11-12 |
HRP20150697T8 (xx) | 2015-11-06 |
ES2540962T3 (es) | 2015-07-15 |
AU2010212560B2 (en) | 2016-01-21 |
CA2751478A1 (en) | 2010-08-19 |
PT2396325E (pt) | 2015-08-21 |
EP2396325B1 (en) | 2015-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201500175B (it) | Derivati di azaindoli come inibitori delle proteine chinasi abl e src | |
SMT201600220B (it) | Derivati di eterociclile biciclici come inibitori di fgfr chinasi per uso terapeutico | |
CY2023023I1 (el) | Παραγωγα λακταμης χρησιμα ως αναστολεις μεταλλαγμενης idh1 | |
SMT201500195B (it) | Derivati di chinolina e chinossalina quali inibitori delle chinasi | |
SMT201500191B (it) | Derivati di benzopirazina sostituiti come inibitori delle chinasi fgfr per il trattamento di malattie tumorali | |
LTPA2019006I1 (lt) | Junginiai ir kompozicijos kaip proteinkinazės inhibitoriai | |
SMT201500076B (it) | Derivati di chinazolin-4(3H)-one utilizzati come inibitori della PI3 chinasi | |
SMT201400086B (it) | Derivati chinazolin-4(3H)-one usati come inibitoridi PI3 chinasi | |
SMT201500200B (it) | Derivati di imidazo[1,2-a]piridina come inibitori delle chinasi fgfr per l'uso in terapia | |
SMT201300114T1 (it) | Derivati di piridazina come inibitori di smo | |
SMT201600338B (it) | Formulazioni farmaceutiche comprendenti derivati di1-(beta-d- glucopiranosil)- 2-tienilmetilbenzene come inibitori di sglt | |
SMT201600005B (it) | Derivati di picolinammide quali inibitori di chinasi | |
SMAP200800048A (it) | Derivati pirimidinici utilizzati come inibitori dip13-chinasi | |
HK1215578A1 (zh) | 作為蛋白激酶抑制劑的氮雜吲哚衍生物 | |
SMT201400114B (it) | Derivati di 2-arilimidazolo come inibitori dell'enzima pde10a | |
BRPI1012333A2 (pt) | atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso | |
DK3100728T3 (da) | Farmaceutiske sammensætninger omfattende prasugrel og cyclodextrin-derivativ og fremgangsmåder til fremstilling og brug af samme | |
SMT201400155B (it) | Composizioni farmaceutiche comprendenti derivati di 2-osso-1-pirrolidina | |
SMT201400009B (it) | Derivati eteroaromatici di ariltriazolo come inibitori dell'enzima pde 10A | |
SMT201500208B (it) | Derivati di piridinone come inibitori della transglutaminasi tissutale | |
SMAP200900065A (it) | Derivati ciclizzati come inibitori di eg-5 | |
SMT201600076B (it) | Derivati di 2-osso-1-pirrolidinil imidazotiadiazolo | |
BR112012006652A2 (pt) | métodos para preparar os derivados de pirimidina úteis como inibidores de proteína cinase | |
SMT201400084B (it) | Nuovi derivati di 6-(osso-1,6diiro-pirimidin-2-il)-ammide, loro preparazione e loro uso farmaceuticocome inibitori di fosforilazione di akt | |
SMT201300067B (it) | Applicazioni terapeutiche di derivati di chinazolindione |